Search - tctmd.com

Displaying 101 - 120 of 143

Sort: Relevancy | Date

News Conference News AHA 2018

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Shelley Wood

November 13, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Conference News AHA 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Shelley Wood

November 10, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Acute MI Rates on the Rise Among Pregnant Women in the US

Caitlin E. Cox

July 24, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

News Conference News ACC 2018

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

Yael L. Maxwell

March 10, 2018

News Daily News

‘High Index of Suspicion’ First Step in Successful Management of SCAD

Michael O'Riordan

February 27, 2018

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Daily News

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

Michael O'Riordan

October 05, 2017

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

News Daily News

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

Michael O'Riordan

June 28, 2017

News Industry News

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

May 12, 2017

News Conference News ACC 2017

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Michael O'Riordan

March 17, 2017

Advertisement

TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Acute MI Rates on the Rise Among Pregnant Women in the US

Discharge Against Medical Advice After PCI Rare but Deadly

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

‘High Index of Suspicion’ First Step in Successful Management of SCAD

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

CTA Reduces MI Compared With Functional Stress Testing, but at a Cost

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Cardiac Testing in Chest Pain Patients Without Ischemia Does Not Reduce Acute MI Admissions

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content